drugset / Trial / NCT04261179
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
Comparison of the concordance of albumin nanocolloid and Lymphoseek® in the detection of lymph nodes of primary and secondary stage drainage by performing two lymphogammagrams
Timeline
- Start
- 2020-03
- Primary completion
- 2021-02
- Completion
- 2021-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nanocoll | Diagnostic / imaging agent | 500 ug | — |
| Subject | Technetium Tc 99m Tilmanocept | Diagnostic / imaging agent | 50 ug | — |